Sponsored
Biopharmaceuticals Contract Manufacturing Market To Surpass USD 5.72 Billion at a 9.19%. CAGR by 2029
The growing popularity of biologics has resulted in a shift in the healthcare paradigm. The US FDA has gradually raised the number of biopharmaceutical approvals over the last decade. In specifically, the US approved 28 biopharmaceutical medications in 2022 (including monoclonal antibodies, recombinant proteins, and gene therapies). Furthermore, about 8,000 biological medical medicines are now...
0 Comments 0 Shares 1289 Views
Sponsored
Sponsored
Sponsored